Literature DB >> 27324830

Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis.

E Zomer1,2, K Gurusamy3, R Leach4, C Trimmer4, T Lobstein4, S Morris3, W P T James4,5, N Finer4,3.   

Abstract

Overweight and obesity increase the risks of diabetes and cardiovascular disease (CVD). This has been shown to be reversed with weight loss. A systematic review and meta-analysis were performed to determine the effect of weight loss in the primary prevention of CVD. PubMed, Embase and the Cochrane Library databases were searched electronically through to May 2013. Randomized controlled trials assessing weight loss and cardiovascular risk factors and outcomes were included. A random effects meta-analysis, with sub-group analyses for degree of weight loss, and age were performed. Because few studies reported clinical outcomes of CVD, analyses were limited to cardiovascular risk factors (83 studies). Interventions that caused any weight loss significantly reduced systolic blood pressure (-2.68 mmHg, 95% CI -3.37, -2.11), diastolic blood pressure (-1.34 mmHg, 95% CI -1.71, -0.97), low-density lipoprotein cholesterol (-0.20 mmol L(-1) , 95% CI -0.29, -0.10), triglycerides (-0.13 mmol L(-1) , 95% CI -0.22, -0.03), fasting plasma glucose (-0.32 mmol L(-1) , 95% CI -0.43, -0.22) and haemoglobin A1c(-0.40%, 95% CI -0.52, -0.28) over 6-12 months. Significant changes remained after 2 years for several risk factors. Similar results were seen in sub-group analyses. Interventions that cause weight loss are effective at improving cardiovascular risk factors at least for 2 years.
© 2016 World Obesity. © 2016 World Obesity.

Entities:  

Keywords:  Cardiovascular disease; cardiovascular risk factors; obesity; weight loss

Mesh:

Year:  2016        PMID: 27324830     DOI: 10.1111/obr.12433

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  40 in total

Review 1.  Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure.

Authors:  André J Scheen
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 2.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.

Authors:  Luigi Ferrucci; Elisa Fabbri
Journal:  Nat Rev Cardiol       Date:  2018-09       Impact factor: 32.419

Review 3.  Hypertension.

Authors:  Suzanne Oparil; Maria Czarina Acelajado; George L Bakris; Dan R Berlowitz; Renata Cífková; Anna F Dominiczak; Guido Grassi; Jens Jordan; Neil R Poulter; Anthony Rodgers; Paul K Whelton
Journal:  Nat Rev Dis Primers       Date:  2018-03-22       Impact factor: 52.329

4.  Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.

Authors:  Michael J Wilkinson; Emily N C Manoogian; Adena Zadourian; Hannah Lo; Savannah Fakhouri; Azarin Shoghi; Xinran Wang; Jason G Fleischer; Saket Navlakha; Satchidananda Panda; Pam R Taub
Journal:  Cell Metab       Date:  2019-12-05       Impact factor: 27.287

5.  Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland.

Authors:  Christiane Lundegaard Haase; Maria Giovanna Serratore Achenbach; Gianluca Lucrezi; Nikita Jeswani; Susanne Maurer; Ulrich Egermann
Journal:  Obes Facts       Date:  2021-08-20       Impact factor: 3.942

6.  Weight Change, Lifestyle, and Mortality in Patients With Type 2 Diabetes.

Authors:  Jinbo Hu; Yang Hu; Ellen Hertzmark; Chen Yuan; Gang Liu; Meir J Stampfer; Eric B Rimm; Frank B Hu; Molin Wang; Qi Sun
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

Review 7.  Management of Dyslipidemia in Endocrine Diseases.

Authors:  Lisa R Tannock
Journal:  Endocrinol Metab Clin North Am       Date:  2022-07-06       Impact factor: 4.748

Review 8.  Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.

Authors:  Gerd Flodgren; Daniela C Gonçalves-Bradley; Carolyn D Summerbell
Journal:  Cochrane Database Syst Rev       Date:  2017-11-30

Review 9.  The Diagnosis and Treatment of Hypertriglyceridemia.

Authors:  Klaus G Parhofer; Ulrich Laufs
Journal:  Dtsch Arztebl Int       Date:  2019-12-06       Impact factor: 5.594

10.  A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors.

Authors:  Jennifer R Bail; Andrew D Frugé; Mallory G Cases; Jennifer F De Los Santos; Julie L Locher; Kerry P Smith; Alan B Cantor; Harvey J Cohen; Wendy Demark-Wahnefried
Journal:  Cancer       Date:  2018-06-22       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.